Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Bariatric Surgery on Metabolism and Microbiome in Type 2 Diabetes
NCT02762708Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Mar 2016
- Primary completion
- Jan 2018
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial (4 arms), sponsored by Mayo Clinic. Primary endpoints: Fasting Glucose at 4 weeks, Peak Glucose at 4 weeks and 2 more. Started Mar 2016; status: completed.
Beyond the preview
Go deeper on NCT02762708.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02762708.